<p>➀ A Swiss-led study involving ETH Zürich, Universitätsspital Zürich, and Roche used nine molecular technologies to create detailed tumor profiles within four weeks, enabling personalized treatment for melanoma patients;</p><p>➁ Each tumor sample generated ~43,000 data points (0.5 TB), with 75% of oncologists finding the AI-assisted recommendations actionable;</p><p>➂ The study pioneers data-driven oncology, showcasing potential for predictive therapy selection and paving the way for future clinical trials focused on treatment optimization.</p>